China News Service, Guangzhou, March 1 (Reporter Cai Minjie) In order to promote the improvement of the standardized diagnosis and treatment of asthma in my country, the "New Breath" Chinese Asthma Patient Online Registration Database System Construction Project was recently held at the First Affiliated Hospital of Guangzhou Medical University. The second phase of the project was signed. ceremony.
The project plans to improve the disease control level of Chinese asthma patients by establishing a demonstration area for standardized management and treatment of asthma, and establishing a collaborative network and database for the management of asthma patients in China through mobile Internet medical technology.
Zhong Nanshan, an academician of the Chinese Academy of Engineering, said at the signing ceremony, "The second-phase project 'New Breath' hopes to actively promote the formulation of asthma clinical diagnosis and treatment norms by establishing a national asthma patient registration platform based on standard asthma medical records, as well as data collection and database sharing for asthma single disease. , so as to improve the level of asthma diagnosis and treatment and scientific research, and on this basis, promote the basic and clinical translational research in the field of asthma in China; at the same time, it provides data reference for relevant government departments in my country to formulate health and medical insurance policies, benefiting more Chinese asthma patients. "
According to a research survey published in The Lancet in 2019, the prevalence of asthma among people aged 20 and above in my country was 4.2%, with 45.7 million adults. 10,000 patients with pulmonary function airflow limitation, and only 5.6% of the patients received standardized inhaled glucocorticoid therapy, revealing the severe situation of insufficient standardized diagnosis and treatment and management of asthma in my country, and highlighting the urgency of comprehensive measures to improve the overall prevention and treatment of asthma in my country Sex and significance.
According to Professor Lai Kefang, director of the Clinical Experiment Department of the Guangzhou Institute of Respiratory Health and the State Key Laboratory of Respiratory Diseases, the first phase of the above-mentioned project "New Breath, Always Care" was launched in December 2017, and 58 hospitals in 10 regions have participated. More than 20,000 asthma patients were included.
The second phase of the project, "New Breath", plans to invite 110 hospitals across the country to participate in the registration of clinical data for about 18,000 asthma patients.
Dr. Pauline Ng, Vice President of GSK China and Head of China Prescription Medicine Department, said: "Through this cooperation with Guangzhou Institute of Respiratory Health, I look forward to continuously promoting the close cooperation between GSK and China's respiratory clinical and scientific research forces, helping to improve doctors The level of asthma diagnosis and treatment and the patient's self-management ability of the disease."
After the signing ceremony, the two parties had a heated discussion on how the project should work with relevant units at all levels to establish a standard electronic medical record for asthma and build a national online registration database system for asthma patients, in order to provide more basis for the standardized diagnosis and treatment of asthma patients in China. Improve the overall level of asthma control in China.
(over)